Christopher P. Acevedo

CIK: 0002010225

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

OSTX

OS Therapies Inc

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

OSTX
OS Therapies Inc
Jan 22, 2026
Award(A)
Stock options (right to buy)
Direct
100K shares-
OSTX
OS Therapies Inc
Oct 21, 2025
Award(A)
Stock options (right to buy)
Direct
200K shares-
OSTX
OS Therapies Inc
Dec 5, 2024
Award(A)
Non-qualified stock options (right to buy)
Direct
200K shares-

		Type	Shares	Price		Ownership
Jan 22, 2026	OSTX OS Therapies Inc	Award(A) Stock options (right to buy)	100,000	-	-	Direct
Oct 21, 2025	OSTX OS Therapies Inc	Award(A) Stock options (right to buy)	200,000	-	-	Direct
Dec 5, 2024	OSTX OS Therapies Inc	Award(A) Non-qualified stock options (right to buy)	200,000	-	-	Direct

1-3 of 3 transactions

About Acevedo Christopher P.

Acevedo Christopher P. (SEC CIK 0002010225) files insider reports with the SEC as Chief Financial Officer of OS Therapies Inc (OSTX).

Signal8 holds 3 ownership filings by Acevedo Christopher P. (2 Form 4, 1 Form 5), filed between Feb 14, 2025 and Feb 13, 2026. Those filings report 3 transactions, from Dec 5, 2024 to Jan 22, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Acevedo Christopher P.'s filings is in GRASONVILLE, MD.

Recent filings by Acevedo Christopher P.

Jan 22, 2026: Grant or award of OSTX derivative securities (Form 4, code A).
Oct 21, 2025: Grant or award of OSTX derivative securities (Form 4, code A).
Dec 5, 2024: Grant or award of OSTX derivative securities (Form 5, code A).

Other insiders filing for OS Therapies Inc (OSTX)

How to read Form 4 transaction codes